Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Assessing an Epidemic

Assessing an Epidemic Abstract Background Inpatient psychiatric hospitals provide an important point of care for assessing and stabilizing substance use and for facilitating linkage to appropriate treatment. Toxicology screening provides a key measure of substance use yet may miss many cases of substance use because of variable windows of detection and the limited scope of substances assessed. This study assesses the utility of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) Level 2 Substance Use screener as a supplemental tool for identifying substance use by self-report within an inpatient psychiatric hospital setting. Methods From a larger sample of 97 adult psychiatric inpatients, 60 who underwent drug toxicology testing and completed the DSM-5 screener were assessed. We examined the sensitivity and specificity of the self-report screener in comparison with drug toxicology test results collected by chart review. Results Sensitivity of the DSM-5 screener varied across substances assessed: The self-report measure identified 100% of individuals who tested positive for opioid use, 83% who tested positive for cannabis use, 50% who tested positive for cocaine use, and 37% who tested positive for benzodiazepine use. The self-report measure also identified 27 instances among 60 participants in which substance use identified by self-report was not detected by toxicology testing. Conclusion The brief and easily administered DSM-5 Level 2 Substance Use screener shows promise for improving identification of substance use in an inpatient psychiatric hospital setting. This measure may also provide psychiatric inpatient nursing staff with a means of working collaboratively with patients to assess substance use and coordinate appropriate treatment plans. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Addictions Nursing Wolters Kluwer Health

Assessing an Epidemic

Download PDF
8 pages

Loading next page...
 
/lp/wolters-kluwer-health/assessing-an-epidemic-edkGA0ag00
Publisher
Wolters Kluwer Health
Copyright
Copyright © 2020 International Nurses Society on Addictions
ISSN
1088-4602
eISSN
1548-7148
DOI
10.1097/JAN.0000000000000318
Publisher site
See Article on Publisher Site

Abstract

Abstract Background Inpatient psychiatric hospitals provide an important point of care for assessing and stabilizing substance use and for facilitating linkage to appropriate treatment. Toxicology screening provides a key measure of substance use yet may miss many cases of substance use because of variable windows of detection and the limited scope of substances assessed. This study assesses the utility of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) Level 2 Substance Use screener as a supplemental tool for identifying substance use by self-report within an inpatient psychiatric hospital setting. Methods From a larger sample of 97 adult psychiatric inpatients, 60 who underwent drug toxicology testing and completed the DSM-5 screener were assessed. We examined the sensitivity and specificity of the self-report screener in comparison with drug toxicology test results collected by chart review. Results Sensitivity of the DSM-5 screener varied across substances assessed: The self-report measure identified 100% of individuals who tested positive for opioid use, 83% who tested positive for cannabis use, 50% who tested positive for cocaine use, and 37% who tested positive for benzodiazepine use. The self-report measure also identified 27 instances among 60 participants in which substance use identified by self-report was not detected by toxicology testing. Conclusion The brief and easily administered DSM-5 Level 2 Substance Use screener shows promise for improving identification of substance use in an inpatient psychiatric hospital setting. This measure may also provide psychiatric inpatient nursing staff with a means of working collaboratively with patients to assess substance use and coordinate appropriate treatment plans.

Journal

Journal of Addictions Nursing – Wolters Kluwer Health

Published: Jan 1, 2020

References

  • Detection window for drugs of abuse
  • Assessment measures
  • Single-session motivational interviewing for drug detoxification inpatients: Effects on self-efficacy, stages of change and substance use
    Berman, A. H.; Forsberg, L.; Durbeej, N.; Källmén, H.; & Hermansson, U.
  • Synthetic cannabinoid use among patients in residential substance use disorder treatment: Prevalence, motives, and correlates
    Bonar, E. E.; Ashrafioun, L.; & Ilgen, M. A.
  • Key substance use and mental health indicators in the United States: Results from the 2015 national survey on drug use and health (HHS Publication No. SMA 16-4984, NSDUH Series H-51)
  • Underreporting of illicit drug use by patients at emergency departments as revealed by two-tiered urinalysis
    Chen, W. J.; Fang, C.; Shyu, R.; & Lin, K.
  • Psychiatric mental health nursing workforce agenda: Optimizing capabilities and capacity to address workforce demands
    Delaney, K. R.
  • The course, treatment, and outcome of substance disorder in persons with severe mental illness
    Drake, R. E.; Mueser, K. T.; Clark, R. E.; & Wallach, M. A.
  • Objective testing: Urine and other drug tests
    Hadland, S. E.; & Levy, S.
  • United States registered nurse workforce report card and shortage forecast
    Juraschek, S. P.; Zhang, X.; Ranganathan, V.; & Lin, V. W.
  • The prescription opioid and heroin crisis: A public health approach to an epidemic of addiction
    Kolodny, A.; Courtwright, D. T.; Hwang, C. S.; Kreiner, P.; Eadie, J. L.; Clark, T. W.; & Alexander, G. C.
  • The PHQ-9: Validity of a brief depression severity measure
    Kroenke, K.; Spitzer, R. L.; & Williams, J. B.
  • The validity and utility of risk assessment for inpatient suicide
    Large, M.; Ryan, C.; & Nielssen, O.
  • Insurance financing increased for mental health conditions but not for substance use disorders, 1986–2014
    Mark, T. L.; Yee, T.; Levit, K. R.; Camacho-Cook, J.; Cutler, E.; & Carroll, C. D.
  • Validation of an audio computer-assisted self-interview (ACASI) version of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in primary care patients
    McNeely, J.; Strauss, S. M.; Rotrosen, J.; Ramautar, A.; & Gourevitch, M. N.
  • Predictive validity despite social desirability: Evidence for the robustness of self-report among offenders
    Mills, J. F.; Loza, W.; & Kroner, D. G.
  • Nursing care in alcohol and drug user treatment facilities
    Naegle, M. A.
  • The reliability and validity of drug users' self reports of amphetamine use among primarily heroin and cocaine users
    Napper, L. E.; Fisher, D. G.; Johnson, M. E.; & Wood, M. M.
  • NIDA-modified Alcohol, Smoking and Substance Involvement Screening Test (ASSIST)
  • The predictive validity of the short-term assessment of risk and treatability (START) for multiple adverse outcomes in a secure psychiatric inpatient setting
    O'Shea, L. E.; Picchioni, M. M.; & Dickens, G. L.
  • Substance use treatment barriers for patients with frequent hospital admissions
    Raven, M. C.; Carrier, E. R.; Lee, J.; Billings, J. C.; Marr, M.; & Gourevitch, M. N.
  • What's the agreement between self-reported and biochemical verification of drug use? A look at permanent supportive housing residents
    Rendon, A.; Livingston, M.; Suzuki, S.; Hill, W.; & Walters, S.
  • Co-occurring psychotic and addictive disorders: Neurobiology and diagnosis
    Ross, S.; & Peselow, E.
  • Income and poverty in the United States: 2016
    Semega, J. L.; Fontenot, K. R.; & Kollar, M. A.
  • Validity of patients' self-reported drug use as a function of treatment status
    Sherman, M. F.; & Bigelow, G. E.
  • A single-question screening test for drug use in primary care
    Smith, P. C.; Schmidt, S. M.; Allensworth-Davies, D.; & Saitz, R.
  • PROMIS®-assessed sleep problems and physical health symptoms in adult psychiatric inpatients
    Strainge, L.; Sullivan, M. C.; Blackmon, J. E.; Cruess, S. E.; Wheeler, D.; & Cruess, D. G.
  • Patient and program factors that bridge the detoxification-treatment gap: A structured evidence review
    Timko, C.; Below, M.; Schultz, N. R.; Brief, D.; & Cucciare, M. A.
  • Comparing the validity of self-report and urinalysis for substance use among former inmates in the northeastern United States
    van den Berg, J. J.; Adeyemo, S.; Roberts, M. B.; Bock, B. C.; Stein, L. A. R.; Martin, R. A.; … Clarke, J. G.
  • Substance use in individuals with mild to borderline intellectual disability: A comparison between self-report, collateral-report and biomarker analysis
    VanDerNagel, J. E.; Kiewik, M.; van Dijk, M.; Didden, R.; Korzilius, H. P.; van der Palen, J.; … de Jong, C. A.